![Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML](https://www.mdpi.com/cancers/cancers-14-01493/article_deploy/html/images/cancers-14-01493-g001.png)
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML
![Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41571-020-00432-6/MediaObjects/41571_2020_432_Fig1_HTML.png)
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology
![Biomarker assessment and molecular testing for prognostication in breast cancer - Kos - 2016 - Histopathology - Wiley Online Library Biomarker assessment and molecular testing for prognostication in breast cancer - Kos - 2016 - Histopathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/38d1b028-1390-4df8-aaf9-e424701dcb9b/his.2016.68.issue-1.cover.jpg?trick=1663605707457)
Biomarker assessment and molecular testing for prognostication in breast cancer - Kos - 2016 - Histopathology - Wiley Online Library
![PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e977c065bbeedc4ec3317993fa3477329dffa910/4-TableI-1.png)
PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar
![A Bad Tumor Marker Test Is as Bad as a Bad Drug: The Case for More Consistent Regulation of Cancer Diagnostics | ASCO Connection A Bad Tumor Marker Test Is as Bad as a Bad Drug: The Case for More Consistent Regulation of Cancer Diagnostics | ASCO Connection](https://connection.asco.org/sites/asco_connection/files/Commentary/Bad-Tumor-Marker-Figure-1-2016.jpg)
A Bad Tumor Marker Test Is as Bad as a Bad Drug: The Case for More Consistent Regulation of Cancer Diagnostics | ASCO Connection
![Cell‐free tumour DNA testing for early detection of cancer – a potential future tool - Barbany - 2019 - Journal of Internal Medicine - Wiley Online Library Cell‐free tumour DNA testing for early detection of cancer – a potential future tool - Barbany - 2019 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2571af82-03aa-4c22-a987-a14b20e38c12/joim12897-toc-0001-m.png)
Cell‐free tumour DNA testing for early detection of cancer – a potential future tool - Barbany - 2019 - Journal of Internal Medicine - Wiley Online Library
![Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer | SpringerLink Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-020-02529-x/MediaObjects/12094_2020_2529_Fig1_HTML.png)
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer | SpringerLink
![Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types](https://www.frontiersin.org/files/Articles/645159/fonc-11-645159-HTML/image_m/fonc-11-645159-t003.jpg)
Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
![Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types](https://www.frontiersin.org/files/Articles/645159/fonc-11-645159-HTML/image_m/fonc-11-645159-g005.jpg)
Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
![Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | npj Breast Cancer Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-020-0156-0/MediaObjects/41523_2020_156_Fig1_HTML.png)